UnitedHealth Group is rallying following the release of its third-quarter 2026 results, which featured earnings of $4.69 per share that significantly outperformed the consensus estimate of $4.12. The company also raised its full-year profit outlook as it continues to successfully manage medical costs, achieving a medical-cost ratio of 88.4% for the quarter. This strong performance has lifted the broader healthcare sector, with peers such as Centene, Elevance Health, and CVS Health all posting gains in sympathy with the positive momentum.